Why the study?
Few studies compare different renal replacement therapies in acute cardiorenal syndrome, and evidence in diuretic resistance is lacking, raising the question of potential advantages beyond fluid removal.
Could there be an advantage of a specific renal replacement modality beyond fluid removal in patients with acute cardiorenal syndrome and diuretic resistance?
Comparison
Peritoneal dialysis vs extracorporeal ultrafiltration modalities
Key result
Peritoneal dialysis and continuous renal replacement therapy offer hemodynamic advantages in acute cardiorenal syndrome, but the scarcity of comparative studies underscores the need for randomized trials.
Authors
Loading...
Supports individualized renal replacement in diuretic-resistant cardiorenal syndrome; leaves open optimal modality selection without randomized comparisons.
Could there be an advantage of a specific renal replacement modality beyond fluid removal in patients with acute cardiorenal syndrome and diuretic resistance?
There is a scarcity of comparative studies between peritoneal dialysis and continuous renal replacement therapy in acute cardiorenal syndrome with diuretic resistance, highlighting the need for randomized trials.
Zamora-Cervantes et al. (2026) conducted a review in Acute Cardiorenal Syndrome with Diuretic Resistance. Peritoneal dialysis vs. Continuous renal replacement therapy (CRRT) was evaluated. Peritoneal dialysis and continuous renal replacement therapy offer hemodynamic advantages in acute cardiorenal syndrome, but the scarcity of comparative studies underscores the need for randomized trials.